Study Stopped
to much uncertainty about possibilities for recruiting
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD
ADHD
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
ADHD is associated with a substantial burden on families, and systems pertaining to health, social care, and criminal justice, and there is a need for more knowledge of the effects of non-pharmacological interventions. Educational and parental activation interventions may improve ADHD symptoms, and may enhance parent activation. Although the results of these studies are promising, few interventions have been carried out in collaboration with user representatives, which is required by Norwegian legislation. As such, there is a need for clinical studies that document the effects of educational group interventions based on user involvement that seeks to improve parental activation. Furthermore, it is not clear which type of educational intervention that should be offered, and which aspects of parenting behaviour to focus on. There is a lack of studies investigating whether adding an intervention designed specifically for families of children with ADHD will be more effective than treatment as usual (TAU). The purpose of the present study is to determine the feasibility and expected size of a substantive randomized controlled trial comparing an ADHD peer co-led educational programme added to TAU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2019
CompletedFirst Posted
Study publicly available on registry
July 8, 2019
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFebruary 14, 2022
January 1, 2022
1.3 years
June 28, 2019
January 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility of recruitment
Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.
Over a two year study period
Satisfaction with the intervention
Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme. The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).
From baseline to 12- and 52-weeks follow-up
Parental activation
Parental activation will be measure with the P-PAM-13. The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.
From baseline to 12- and 52-weeks follow-up
Secondary Outcomes (8)
Parental well-being
From baseline to 12- and 52-weeks follow-up
Parental quality of life
From baseline to 12- and 52-weeks follow-up
Shared decision making
From baseline to 12- and 52-weeks follow-up
Parental involvement in treatment decision
From baseline to 12- and 52-weeks follow-up
Beliefs about medicines
From baseline to 12- and 52-weeks follow-up
- +3 more secondary outcomes
Other Outcomes (1)
Participation in treatment
From baseline to 12- and 54-weeks follow-up.
Study Arms (2)
Peer co-led educational group
EXPERIMENTALThe intervention delivered in a group format is added to treatment as usual. After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.
Control group
OTHERThe control goup will receive treatment as usual.
Interventions
The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.
Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise. These interventions include: medication, psychotherapy, or a combination of these two approaches.
Eligibility Criteria
You may qualify if:
- Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a standardised assessment.
You may not qualify if:
- Participants already taking part in research on a parenting intervention will also be ineligible to participate.
- Families attending other parenting groups
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- Molde University Collegecollaborator
Related Publications (1)
Mundal I, Grawe RW, Hafstad H, De Las Cuevas C, Lara-Cabrera ML. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol. BMJ Open. 2020 Dec 2;10(12):e039852. doi: 10.1136/bmjopen-2020-039852.
PMID: 33268416DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingunn P. Mundal, PhD
Molde University College
- PRINCIPAL INVESTIGATOR
Mariela Loreto Lara Cabrera, PhD
St Olavs Hospital, Department of research and development AFFU, and NTNU
- STUDY DIRECTOR
Rolf W. Gråwe, Phd prof
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2019
First Posted
July 8, 2019
Study Start
March 1, 2022
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
February 14, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share
We anticipate that anonymised trial data may be shared with other researchers to enable international prospective meta-analyses.